Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo

International Journal of Antimicrobial Agents

Volumn 38, Issue 4, 2011, Pages 360-363

  Calvo, Enrique ^a   Pastor, F Javier ^a   Mayayo, Emilio ^a   Guarro, Josep ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Anidulafungin; Aspergillus niger; Mice

Indexed keywords

ANIDULAFUNGIN; GALACTOMANNAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFICACY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS NIGER; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ECHINOCANDINS; MALE; MICE; MICROBIAL SENSITIVITY TESTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80052264675     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.06.008     Document Type: Article

References (15)

1. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
2. J. Guarro, M.O. Xavier, and L.C. Severo Differences and similarities amongst pathogenic Aspergillus species A.C. Pasqualotto, Aspergillosis: from diagnosis to prevention 2010 Springer Dordrecht, The Netherlands 7 32
3. P.E. Verweij, S.J. Howard, W.J. Merchers, and D.W. Denning Azole-resistance in Aspergillus: proposed nomenclature and breakpoints Drug Resist Updat 12 2009 141 147
4. F.J. Pastor, and J. Guarro Anidulafungin: experimental therapy of fungal infections in animal models Rev Iberoam Micol 25 2008 119 123 [in Spanish] (Pubitemid 351798339)
5. E. Calvo, F.J. Pastor, E. Mayayo, V. Salas, and J. Guarro In vitro activity and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus Antimicrob Agents Chemother 55 2011 1290 1292
6. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. 2nd ed. Document M38-A2. Wayne, PA: CLSI; 2008.
7. Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of filamentous fungi; proposed guideline. Document M51-P. Wayne, PA: CLSI; 2009.
8. A. Espinel-Ingroff, B. Arthington-Skaggs, N. Iqbal, D. Ellis, M.A. Pfaller, and S. Messer Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin J Clin Microbiol 45 2007 1811 1820 (Pubitemid 46933912)
9. L. Fianchi, M. Picardi, L. Cudillo, L. Corbata, L. Mele, and G. Trap Aspergillus niger infection in patients with haematological diseases: a report of eight cases Mycoses 47 2004 163 167 (Pubitemid 38570091)
10. Z. Shimoni, A. Goldenberg, and M. Niven Fatal invasive pulmonary aspergillosis presenting as profound hypoglycemia in a patient with anorexia nervosa Eur J Intern Med 17 2006 295 297 (Pubitemid 43833403)
11. M.O. Xavier, Mda Sales P, J. Camargo Jde, A.C. Pasqualotto, and L.C. Severo Aspergillus niger causing tracheobronchitis and invasive pulmonary aspergillosis in a lung transplant recipient: case report Rev Soc Bras Med Trop 41 2008 200 201 (Pubitemid 351872403)
12. A.K. Person, S.M. Chudgar, B.L. Norton, B.C. Tong, and J.E. Stout Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis J Med Microbiol 59 2010 834 838
13. N.P. Wiederhold, D.P. Kontoyiannis, J. Chi, R.A. Prince, V.H. Tam, and R.E. Lewis Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity J Infect Dis 15 2004 1464 1471 (Pubitemid 39332186)
14. M.C. Arendrup, S. Perkhofer, S.J. Howard, G. Garcia-Effron, A. Vishukumar, and D. Perlin Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins Antimicrob Agents Chemother 52 2008 3504 3511
15. V. Salas, F.J. Pastor, M.M. Rodríguez, E. Calvo, E. Mayayo, and J. Guarro In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex Antimicrob Agents Chemother 55 2011 676 679